DETSK FAKULTN NEMOCNICA S POLIKLINIKOU BANSK BYSTRICA
A United Kingdom buyer, with 2 published contracts, worth £770k, most recently 8 months ago.
Top 2 suppliers won 100% of awarded value — £770k of £770k across 2 awards.
This contract involves the procurement of a medication containing the active ingredient Velmanase alpha, in a dosage of 10 mg as a powder for infusion solution. The product is intended for intravenous use and is presented as a white to almost white powder. It is indicated for enzyme replacement ther
This contract is for the procurement of a medication containing the active ingredient blinatumomab, specifically a powder for infusion concentrate. Each vial contains 38.5 micrograms of blinatumomab, which, when reconstituted with sterile water, results in a final concentration of 12.5 micrograms/ml
